Ioannis A Vathiotis (Ioannis Vathiotis)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 39

Top Topics

Locally Advanced

Squamous Cell Carcinoma

Gene Expression

Top Venues

Journal for immunotherapy of cancer

NPJ precision oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Myrto K Moutafi, Katherine M Bates, Thazin Nwe Aung, Rolando Garcia Milian, Vasiliki Xirou, Ioannis A Vathiotis, Niki Gavrielatou, Athanasios Angelakis, Kurt A Schalper, Leonidas Salichos, David L Rimm
High-throughput transcriptome profiling indicates ribosomal RNAs to be associated with resistance to immunotherapy in non-small cell lung cancer (NSCLC). Journal for immunotherapy of cancer 12 (6) (2024)
Emmanouil Panagiotou, Sofia Ntouraki, Ioannis A Vathiotis, Maria Effrosyni Livanou, Athanasios Trimis, Georgios Evangelou, Andriani G Charpidou, Konstantinos Syrigos, Melpomeni Peppa
Endocrine Immune-Related Adverse Events Are Independent Predictors of Survival in Patients with Lung Cancer. Cancers 16 (9) (2024)
Georgios Evangelou, Ioannis P Trontzas, Ioannis Gkiozos, Ioannis Vamvakaris, Christina Paraskeva, Maria Grammoustianou, Georgia Gomatou, Ioannis Tsamis, Ioannis A Vathiotis, Maximillian Anagnostakis, Vasiliki Koliaraki, Kostas Syrigos
The Effectiveness of Atezolizumab in Metastatic Large Cell Neuroendocrine Carcinoma of the Lungs: Insights from the LANCE Pilot Study. Biomedicines 12 (6) (2024)
Myrto K Moutafi, Katherine M Bates, Thazin Nwe Aung, Rolando Garcia Milian, Vasiliki Xirou, Ioannis A Vathiotis, Niki Gavrielatou, Athanasios Angelakis, Kurt A Schalper, Leonidas Salichos, David L Rimm
High-throughput transcriptome profiling indicates ribosomal RNAs to be associated with resistance to immunotherapy in non-small cell lung cancer (NSCLC). Journal for immunotherapy of cancer 12 (6) (2024)
Marousa Kouvela, Maria Effrosyni Livanou, Dimitra T Stefanou, Ioannis A Vathiotis, Fotini Sarropoulou, Maria Grammoustianou, Evangelos Dimakakos, Nikolaos K Syrigos
Efficacy and Safety of Tinzaparin Thromboprophylaxis in Lung Cancer Patients with High Thromboembolic Risk: A Prospective, Observational, Single-Center Cohort Study. Cancers 16 (7) (2024)
Georgios Evangelou, Ioannis P Trontzas, Ioannis Gkiozos, Ioannis Vamvakaris, Christina Paraskeva, Maria Grammoustianou, Georgia Gomatou, Ioannis Tsamis, Ioannis A Vathiotis, Maximillian Anagnostakis, Vasiliki Koliaraki, Kostas Syrigos
The Effectiveness of Atezolizumab in Metastatic Large Cell Neuroendocrine Carcinoma of the Lungs: Insights from the LANCE Pilot Study. Biomedicines 12 (6) (2024)
Emmanouil Panagiotou, Sofia Ntouraki, Ioannis A Vathiotis, Maria Effrosyni Livanou, Athanasios Trimis, Georgios Evangelou, Andriani G Charpidou, Konstantinos Syrigos, Melpomeni Peppa
Endocrine Immune-Related Adverse Events Are Independent Predictors of Survival in Patients with Lung Cancer. Cancers 16 (9) (2024)
Marousa Kouvela, Maria Effrosyni Livanou, Dimitra T Stefanou, Ioannis A Vathiotis, Fotini Sarropoulou, Maria Grammoustianou, Evangelos Dimakakos, Nikolaos K Syrigos
Efficacy and Safety of Tinzaparin Thromboprophylaxis in Lung Cancer Patients with High Thromboembolic Risk: A Prospective, Observational, Single-Center Cohort Study. Cancers 16 (7) (2024)
Myrto K Moutafi, Katherine M Bates, Thazin Nwe Aung, Rolando Garcia Milian, Vasiliki Xirou, Ioannis A Vathiotis, Niki Gavrielatou, Athanasios Angelakis, Kurt A Schalper, Leonidas Salichos, David L Rimm
High-throughput transcriptome profiling indicates ribosomal RNAs to be associated with resistance to immunotherapy in non-small cell lung cancer (NSCLC). Journal for immunotherapy of cancer 12 (6) (2024)
Marousa Kouvela, Maria Effrosyni Livanou, Dimitra T Stefanou, Ioannis A Vathiotis, Fotini Sarropoulou, Maria Grammoustianou, Evangelos Dimakakos, Nikolaos K Syrigos
Efficacy and Safety of Tinzaparin Thromboprophylaxis in Lung Cancer Patients with High Thromboembolic Risk: A Prospective, Observational, Single-Center Cohort Study. Cancers 16 (7) (2024)
Myrto K Moutafi, Katherine M Bates, Thazin Nwe Aung, Rolando Garcia Milian, Vasiliki Xirou, Ioannis A Vathiotis, Niki Gavrielatou, Athanasios Angelakis, Kurt A Schalper, Leonidas Salichos, David L Rimm
High-throughput transcriptome profiling indicates ribosomal RNAs to be associated with resistance to immunotherapy in non-small cell lung cancer (NSCLC). Journal for immunotherapy of cancer 12 (6) (2024)
Ioannis A Vathiotis, Dimitrios Bafaloukos, Konstantinos N Syrigos, George Samonis
Evolving Treatment Landscape of HER2 -mutant Non-Small Cell Lung Cancer: Trastuzumab Deruxtecan and Beyond. Cancers 15 (4) (2023)
Ioannis P Trontzas, Ioannis A Vathiotis, Kοnstantinos G Kyriakoulis, Amalia A Sofianidi, Zoi Spyropoulou, Andriani G Charpidou, Elias A Kotteas, Konstantinos N Syrigos, null ImmunoTTS Collaborative Group
Takotsubo Cardiomyopathy in Cancer Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Summary of Included Cases. Cancers 15 (9) (2023)
Jennifer M Johnson, Ioannis A Vathiotis, Larry A Harshyne, Ayesha Ali, Voichita Bar Ad, Rita Axelrod, Emily Lorber, Joseph Curry, David M Cognetti, Adam J Luginbuhl, Madalina Tuluc, Scott Keith, Mỹ G Mahoney, Athanassios Argiris
Nivolumab and ipilimumab in combination with radiotherapy in patients with high-risk locally advanced squamous cell carcinoma of the head and neck. Journal for immunotherapy of cancer 11 (8) (2023)
Ioannis A Vathiotis, Dimitrios Bafaloukos, Konstantinos N Syrigos, George Samonis
Evolving Treatment Landscape of HER2 -mutant Non-Small Cell Lung Cancer: Trastuzumab Deruxtecan and Beyond. Cancers 15 (4) (2023)
Ioannis P Trontzas, Ioannis A Vathiotis, Kοnstantinos G Kyriakoulis, Amalia A Sofianidi, Zoi Spyropoulou, Andriani G Charpidou, Elias A Kotteas, Konstantinos N Syrigos, null ImmunoTTS Collaborative Group
Takotsubo Cardiomyopathy in Cancer Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Summary of Included Cases. Cancers 15 (9) (2023)
Ioannis A Vathiotis, Dimitrios Bafaloukos, Konstantinos N Syrigos, George Samonis
Evolving Treatment Landscape of HER2 -mutant Non-Small Cell Lung Cancer: Trastuzumab Deruxtecan and Beyond. Cancers 15 (4) (2023)
Vasiliki Rapti, Thomas Tsaganos, Ioannis A Vathiotis, Nikolaos K Syrigos, Pei-Feng Li, Garyfallia Poulakou
New Insights into SARS-CoV-2 and Cancer Cross-Talk: Does a Novel Oncogenesis Driver Emerge? Vaccines 10 (10) (2022)
Emmanouil Panagiotou, Nikolaos K Syrigos, Andriani Charpidou, Elias A Kotteas, Ioannis A Vathiotis
CD24: A Novel Target for Cancer Immunotherapy. Journal of personalized medicine 12 (8) (2022)
Konstantinos Tsiakos, Niki Gavrielatou, Ioannis A Vathiotis, Loukas G Chatzis, Stamatios Chatzis, Garyfallia Poulakou, Elias Kotteas, Nikolaos K Syrigos
Programmed Cell Death Protein 1 Axis Inhibition in Viral Infections: Clinical Data and Therapeutic Opportunities. Vaccines 10 (10) (2022)
Ioannis P Trontzas, Kοnstantinos G Kyriakoulis, Ioannis A Vathiotis, Alexandros Syrigos, Georgios Kounadis, Sofia Siasiakou, Garyphalia Poulakou
Vaccine-Related Autoimmune Hepatitis: Emerging Association with SARS-CoV-2 Vaccination or Coincidence? Vaccines 10 (12) (2022)
Ioannis A Vathiotis, Leonidas Salichos, Sandra Martinez-Morilla, Niki Gavrielatou, Thazin Nwe Aung, Saba Shafi, Pok Fai Wong, Shlomit Jessel, Harriet M Kluger, Konstantinos N Syrigos, Sarah Warren, Mark B Gerstein, David L Rimm
Baseline gene expression profiling determines long-term benefit to programmed cell death protein 1 axis blockade. NPJ precision oncology 6 (1) (2022)
Ioannis A Vathiotis, Leonidas Salichos, Sandra Martinez-Morilla, Niki Gavrielatou, Thazin Nwe Aung, Saba Shafi, Pok Fai Wong, Shlomit Jessel, Harriet M Kluger, Konstantinos N Syrigos, Sarah Warren, Mark B Gerstein, David L Rimm
Baseline gene expression profiling determines long-term benefit to programmed cell death protein 1 axis blockade. NPJ precision oncology 6 (1) (2022)
Ioannis A Vathiotis, Leonidas Salichos, Sandra Martinez-Morilla, Niki Gavrielatou, Thazin Nwe Aung, Saba Shafi, Pok Fai Wong, Shlomit Jessel, Harriet M Kluger, Konstantinos N Syrigos, Sarah Warren, Mark B Gerstein, David L Rimm
Baseline gene expression profiling determines long-term benefit to programmed cell death protein 1 axis blockade. NPJ precision oncology 6 (1) (2022)
Ioannis P Trontzas, Ioannis A Vathiotis, Christina Economidou, Ioulia Petridou, Georgia Gomatou, Maria Grammoustianou, Ioannis Tsamis, Nikolaos Syrigos, Maximilian Anagnostakis, Eleni Fyta, Vissaria Sakka, Garyphalia Poulakou, Elias A Kotteas, Ekaterini Syrigou
Assessment of Seroconversion after SARS-CoV-2 Vaccination in Patients with Lung Cancer. Vaccines 10 (4) (2022)
Ioannis P Trontzas, Kοnstantinos G Kyriakoulis, Ioannis A Vathiotis, Alexandros Syrigos, Georgios Kounadis, Sofia Siasiakou, Garyphalia Poulakou
Vaccine-Related Autoimmune Hepatitis: Emerging Association with SARS-CoV-2 Vaccination or Coincidence? Vaccines 10 (12) (2022)
Ioannis P Trontzas, Kοnstantinos G Kyriakoulis, Ioannis A Vathiotis, Alexandros Syrigos, Georgios Kounadis, Sofia Siasiakou, Garyphalia Poulakou
Vaccine-Related Autoimmune Hepatitis: Emerging Association with SARS-CoV-2 Vaccination or Coincidence? Vaccines 10 (12) (2022)
Ioannis P Trontzas, Kοnstantinos G Kyriakoulis, Ioannis A Vathiotis, Alexandros Syrigos, Georgios Kounadis, Sofia Siasiakou, Garyphalia Poulakou
Vaccine-Related Autoimmune Hepatitis: Emerging Association with SARS-CoV-2 Vaccination or Coincidence? Vaccines 10 (12) (2022)
Ioannis A Vathiotis, Leonidas Salichos, Sandra Martinez-Morilla, Niki Gavrielatou, Thazin Nwe Aung, Saba Shafi, Pok Fai Wong, Shlomit Jessel, Harriet M Kluger, Konstantinos N Syrigos, Sarah Warren, Mark B Gerstein, David L Rimm
Baseline gene expression profiling determines long-term benefit to programmed cell death protein 1 axis blockade. NPJ precision oncology 6 (1) (2022)
Nikolaos K Syrigos, Anastasios Kollias, Dimitra Grapsa, Eleni Fyta, Kοnstantinos G Kyriakoulis, Ioannis A Vathiotis, Elias Kotteas, Ekaterini Syrigou
Significant Increase in Blood Pressure Following BNT162b2 mRNA COVID-19 Vaccination among Healthcare Workers: A Rare Event. Vaccines 10 (5) (2022)
Myrto K Moutafi, Magdalena Molero, Sandra Martinez Morilla, Javier Baena, Ioannis A Vathiotis, Niki Gavrielatou, Laura Castro-Labrador, Gorka Ruiz de Garibay, Vera Adradas, Daniel Orive, Karmele Valencia, Alfonso Calvo, Luis M Montuenga, S Ponce Aix, Kurt A Schalper, Roy S Herbst, Luis Paz-Ares, David L Rimm, Jon Zugazagoitia
Spatially resolved proteomic profiling identifies tumor cell CD44 as a biomarker associated with sensitivity to PD-1 axis blockade in advanced non-small-cell lung cancer. Journal for immunotherapy of cancer 10 (8) (2022)
Georgia Gomatou, Nikolaos Syrigos, Ioannis A Vathiotis, Elias A Kotteas
Tumor Dormancy: Implications for Invasion and Metastasis. International journal of molecular sciences 22 (9) (2021)
Ioannis A Vathiotis, Tyler MacNeil, Jon Zugazagoitia, Konstantinos N Syrigos, Thazin Nwe Aung, Aaron M Gruver, Peter Vaillancourt, Ina Hughes, Steve Hinton, Kyla Driscoll, David L Rimm
Quantitative Assessment of CD200 and CD200R Expression in Lung Cancer. Cancers 13 (5) (2021)
Niki Gavrielatou, Ioannis A Vathiotis, Panagiota Economopoulou, Amanda Psyrri
The Role of B Cells in Head and Neck Cancer. Cancers 13 (21) (2021)
Myrto K Moutafi, Weiwei Tao, Richard Huang, James Haberberger, Brian Alexander, Shakti Ramkissoon, Jeffrey S Ross, Konstantinos Syrigos, Wei Wei, Lajos Pusztai, David L Rimm, Ioannis A Vathiotis
Comparison of programmed death-ligand 1 protein expression between primary and metastatic lesions in patients with lung cancer. Journal for immunotherapy of cancer 9 (4) (2021)
Ioannis A Vathiotis, Andriani Charpidou, Niki Gavrielatou, Konstantinos N Syrigos
HER2 Aberrations in Non-Small Cell Lung Cancer: From Pathophysiology to Targeted Therapy. Pharmaceuticals (Basel, Switzerland) 14 (12) (2021)
Tyler MacNeil, Ioannis A Vathiotis, Saba Shafi, Thazin Nwe Aung, Jon Zugazagoitia, Aaron M Gruver, Kyla Driscoll, David L Rimm
Multiplex Quantitative Analysis of Tumor-Infiltrating Lymphocytes, Cancer-Associated Fibroblasts, and CD200 in Pancreatic Cancer. Cancers 13 (21) (2021)
Ioannis A Vathiotis, Zhi Yang, Jason Reeves, Maria I Toki, Thazin Nwe Aung, Pok Fai Wong, Harriet Kluger, Konstantinos N Syrigos, Sarah Warren, David L Rimm
Models that combine transcriptomic with spatial protein information exceed the predictive value for either single modality. NPJ precision oncology 5 (1) (2021)
Ioannis A Vathiotis, Georgia Gomatou, Dimitrios J Stravopodis, Nikolaos Syrigos
Programmed Death-Ligand 1 as a Regulator of Tumor Progression and Metastasis. International journal of molecular sciences 22 (10) (2021)